{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["28(5)"],"submitter":["Papalamprakopoulou Z"],"funding":["The present study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (award number: R01DK123205), a Patient-Centered Outcomes Research Institute (PCORI) Award (IHS-1507-31640), the Troup Fund of the Kaleida Health Foundation, and the University at Buffalo Accelerator award."],"pubmed_abstract":["<h4>Background</h4>Facilitated telemedicine is highly effective for hepatitis C virus (HCV) treatment among people with opioid use disorder (OUD). However, the long-term impact of sustained virological response (SVR) through this model of treatment remains unexplored. We examined how people with OUD perceive SVR achieved through facilitated telemedicine.<h4>Methods</h4>We conducted two focus group discussions (FGDs) with nine participants at least 5 years post-SVR through a randomised controlled trial of facilitated telemedicine in opioid treatment programmes (OTPs) (New York State, 2018-2020). Eligibility required active OTP enrolment at the time of FGDs. We used a semi-structured interview guide and performed thematic analysis of FGD transcripts.<h4>Results</h4>Participants had a mean ag"],"journal":["Health expectations : an international journal of public participation in health care and health policy"],"pagination":["e70404"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12457984"],"repository":["biostudies-literature"],"pubmed_title":["Long-Term Benefits Following Hepatitis C Cure Through Facilitated Telemedicine; Experiences of People With Opioid use Disorder Five Years After Achieving a Sustained Virological Response."],"pmcid":["PMC12457984"],"pubmed_authors":["Papalamprakopoulou Z","Dang TH","Updike PF","Gonzalez CJ","Hernandez N","Wethington E","Shapiro MF","Dharia A","Tedesco CJ","Talal AH","Corl C"],"additional_accession":[]},"is_claimable":false,"name":"Long-Term Benefits Following Hepatitis C Cure Through Facilitated Telemedicine; Experiences of People With Opioid use Disorder Five Years After Achieving a Sustained Virological Response.","description":"<h4>Background</h4>Facilitated telemedicine is highly effective for hepatitis C virus (HCV) treatment among people with opioid use disorder (OUD). However, the long-term impact of sustained virological response (SVR) through this model of treatment remains unexplored. We examined how people with OUD perceive SVR achieved through facilitated telemedicine.<h4>Methods</h4>We conducted two focus group discussions (FGDs) with nine participants at least 5 years post-SVR through a randomised controlled trial of facilitated telemedicine in opioid treatment programmes (OTPs) (New York State, 2018-2020). Eligibility required active OTP enrolment at the time of FGDs. We used a semi-structured interview guide and performed thematic analysis of FGD transcripts.<h4>Results</h4>Participants had a mean ag","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025 Oct","modification":"2026-06-03T19:52:32.643Z","creation":"2026-05-01T03:10:34.173Z"},"accession":"S-EPMC12457984","cross_references":{"pubmed":["40990152"],"doi":["10.1111/hex.70404"]}}